(Reuters) -India has approved Johnson & Johnson’s single-dose COVID-19 vaccine for emergency use, health minister Mansukh Mandaviya said in a tweet on Saturday, but the company said it was too early to give a delivery timeline. The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J had said. Fellow U.S. company Pfizer has yet to seek permission for use of its vaccine in India. India has administered 501 million vaccine doses, the largest of any country after China, but little over 10% of its adult population has been inoculated with both doses.

Source: MetroXpress August 07, 2021 09:48 UTC